By Dr Simon Ghaly

Book Chapters

Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2023, 'The role of nutrition in inflammatory bowel disease: Disease associations, management of active disease and maintenance of remission', in Encyclopedia of Human Nutrition: Volume 1-4, Fourth Edition, pp. 669 - 697, http://dx.doi.org/10.1016/B978-0-12-821848-8.00104-9

Journal articles

Alshiwanna B; Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1818 - i1818, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1135

Barnett M; Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1829 - i1829, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1142

Pipicella JL; Wilson W; Ghaly S; Antoniades S; Kate L; Grafton R; Ng W; Sechi A; Somes K; Arnold K; Connor SJ; Andrews JM, 2024, 'P1030 Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1858 - i1859, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1160

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i2023 - i2023, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1259

Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2024, 'P1233 Serum insulin is associated with c-reactive protein and gut microbial diversity in inflammatory bowel disease', Journal of Crohn's and Colitis, 18, pp. i2183 - i2183, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1363

Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i657 - i657, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0416

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i930 - i930, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0592

Pipicella JL; McNamara J; Wilson W; Lynch K; Walker G; Begun J; Lawrance I; Ghaly S; Radford-Smith G; Williams AJ; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1622 - i1623, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1010

Mcnamara J; Alshiwanna B; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JA; Connor SJ, 2024, 'P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1742 - i1742, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1089

Katsoudas N; Tavakoli P; Wu N; Shapiro A; Leach ST; Williams A-J; Paramsothy R; Ghaly S; Connor SJ; Samocha-Bonet D; Lambert K; Hold GL, 2024, 'Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?', Inflamm Bowel Dis, http://dx.doi.org/10.1093/ibd/izad318

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', Journal of Crohn's and Colitis, 17, pp. i542 - i543, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0543

Cheema M; Narouz I; Pipicella J; Garden F; Lynch K; Andrews J; Ghaly S; Connor S, 2023, 'P523 Quality, safety and equity of care outcomes for inflammatory bowel disease patients at four tertiary referral centres in Australia using a cloud based management system Crohn’s Colitis Care (CCCare): A real world observational study.', Journal of Crohn's and Colitis, 17, pp. i650 - i651, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0653

An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Amiss A; Pham H; Wong KF; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams AJ; De Cruz P; Li Wai Suen C; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2023, 'P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn’s disease patients: results from the AURORA Study including ANZIBDC Cohort', Journal of Crohn's and Colitis, 17, pp. i793 - i794, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0793

Suo P; Thin L; Srinivasan A; Winston J; Jeffrey A; Menon S; Ghaly S; Haifer C, 2023, 'P753 Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', Journal of Crohn's and Colitis, 17, pp. i884 - i885, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0883

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly DS; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung C; Chan PW; Mourad FH; Redmond D; Leong R, 2023, '1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL', Gastroenterology, 164, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(23)01488-9

Cheema M; Pipicella JL; Narouz I; Garden F; Cabaero A; Williams A-J; Ng W; Wark G; Antoniades S; Kim A; Haifer C; McGrory L; Lynch KD; Andrews JM; Ghaly DS; Connor SJ, 2023, 'Su1782 QUALITY, SAFETY AND EQUITY OF CARE OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS AT FOUR AUSTRALIAN TERTIARY REFERRAL CENTRES USING THE CLOUD-BASED MANAGEMENT SYSTEM CROHN'S COLITIS CARE (CCCARE) : A REAL WORLD OBSERVATIONAL STUDY', Gastroenterology, 164, pp. S - 679, http://dx.doi.org/10.1016/s0016-5085(23)02580-5

Ghali M; Bensted K; Williams DB; Ghaly S, 2022, 'Type 2 autoimmune pancreatitis associated with severe ulcerative colitis: Three case reports', World Journal of Clinical Cases, 10, pp. 8788 - 8796, http://dx.doi.org/10.12998/wjcc.v10.i24.8788

Gu B; Williams AJ; Ng W; Xuan W; Connor S; Gholamrezaei A; Corte C; Venkatesh K; Ghaly S; Paramsothy S, 2022, 'Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease', World Journal of Gastroenterology, 28, pp. 2597 - 2608, http://dx.doi.org/10.3748/wjg.v28.i23.2597

Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW, 2022, 'Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial', The Lancet Gastroenterology and Hepatology, 7, pp. 141 - 151, http://dx.doi.org/10.1016/S2468-1253(21)00400-3

Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong R, 2021, 'Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)', JOURNAL OF CROHNS & COLITIS, 15, pp. S029 - S029, http://dx.doi.org/10.1093/ecco-jcc/jjab075.029

Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2020-042493

Haifer C; Srinivasan A; An YK; Picardo S; van Langenberg D; Menon S; Begun J; Ghaly S; Thin L, 2021, 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study', Medical Journal of Australia, 214, pp. 128 - 133, http://dx.doi.org/10.5694/mja2.50824

Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2021, 'The role of diet in the pathogenesis and management of inflammatory bowel disease: A review', Nutrients, 13, pp. 1 - 26, http://dx.doi.org/10.3390/nu13010135

Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly DS; Kaakoush NO; Leong RW, 2021, '680 LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) – RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', Gastroenterology, 160, pp. S - 135, http://dx.doi.org/10.1016/s0016-5085(21)01074-x

Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B, 2021, 'SARS-CoV-2 vaccination in patients with inflammatory bowel disease.', GastroHep, 3, pp. 212 - 228, http://dx.doi.org/10.1002/ygh2.473

Reddy Pulusu SS; Srinivasan A; Krishnaprasad K; Cheng D; Begun J; Keung C; Van Langenberg D; Thin L; Mogilevski T; de Cruz P; Radford-Smith G; Flanagan E; Bell S; Kashkooli S; Sparrow M; Ghaly S; Bampton P; Sawyer E; Connor S; Rizvi QUA; Andrews JM; Mahy G; Chivers P; Travis S; CraigLawrance I, 2020, 'Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford', World Journal of Gastroenterology, 26, pp. 4428 - 4441, http://dx.doi.org/10.3748/WJG.V26.I30.4428

McGrath-Cadell L; Bart NK; Lin L; Ghaly S; Holloway CJ, 2020, 'Myocarditis in Crohn's disease: A case report', European Heart Journal - Case Reports, 4, pp. 1 - 6, http://dx.doi.org/10.1093/ehjcr/ytaa120

Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B, 2020, 'Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty', Internal Medicine Journal, 50, pp. 798 - 804, http://dx.doi.org/10.1111/imj.14889

Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PDR; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice', Gut, 69, pp. 801 - 810, http://dx.doi.org/10.1136/gutjnl-2019-320260

Wu Y; Ghaly S; Kerr S; Jackson B; Hanigan K; Martins D; Krishnaprasad K; Mountifield RE; Whiteman DC; Bampton PA; Gearry RB; Radford-Smith GL; Lawrance IC, 2020, 'Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients', Digestive Diseases and Sciences, 65, pp. 1172 - 1179, http://dx.doi.org/10.1007/s10620-019-05818-w

Ghaly S; Kaakoush NO; Hart PH, 2020, 'Effects of UVR exposure on the gut microbiota of mice and humans', Photochemical and Photobiological Sciences, 19, pp. 20 - 28, http://dx.doi.org/10.1039/c9pp00443b

Iliff J; Bart NK; Ghaly S; Granger E; Holloway CJ, 2019, 'Pericardial Mesothelioma in a 35-Year-Old Male With Ulcerative Colitis', Circulation. Cardiovascular imaging, 12, pp. e008659, http://dx.doi.org/10.1161/CIRCIMAGING.118.008659

Ghaly S; Hart PH; Lawrance IC, 2019, 'Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome', Expert Review of Gastroenterology and Hepatology, 13, pp. 1039 - 1048, http://dx.doi.org/10.1080/17474124.2019.1685874

Haifer C; Lawrance IC; Center JR; Clarke MW; Hart PH; Eisman JA; Lucas R; Ghaly S, 2019, 'Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission', Therapeutic Advances in Gastroenterology, 12, http://dx.doi.org/10.1177/1756284819865144

Ghaly S; Kaakoush NO; Lloyd F; McGonigle T; Mok D; Baird A; Klopcic B; Gordon L; Gorman S; Forest C; Bouillon R; Lawrance IC; Hart PH, 2018, 'High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-29759-y

Flanagan E; Gibson PR; Begun J; Ghaly S; Garg M; Andrews JM; Rosella O; Rosella G; Bell SJ, 2018, 'Letter: vedolizumab drug concentrations in neonates following intrauterine exposure', Alimentary Pharmacology and Therapeutics, 48, pp. 1328 - 1330, http://dx.doi.org/10.1111/apt.15027

Ghaly S; Bliuc D; Center JR; Clarke MW; Jones AP; Trend S; Kermode AG; Neale RE; Hart PH, 2018, 'Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans.', The Journal of Steroid Biochemistry and Molecular Biology, 186, pp. 110 - 116, http://dx.doi.org/10.1016/j.jsbmb.2018.10.002

Ghaly S, 2018, 'What is in our treasure chest? Australian pharmaceutical benefits scheme availability and criteria for prescribing biologics', Journal of Gastroenterology and Hepatology (Australia), 33, pp. 12 - 13, http://dx.doi.org/10.1111/jgh.14420

Ghaly S; Kaakoush NO; Lloyd F; Gordon L; Forest C; Lawrance IC; Hart PH, 2018, 'Ultraviolet irradiation of skin alters the faecal microbiome independently of vitamin D in mice', Nutrients, 10, http://dx.doi.org/10.3390/nu10081069

Haifer C; Lucas RM; Clarke MW; Lawrance I; Hart PH; Center JR; Eisman JA; Ghaly S, 2018, 'P120 Vitamin D deficiency in Crohn’s disease', Journal of Crohn's and Colitis, 12, pp. S152 - S153, http://dx.doi.org/10.1093/ecco-jcc/jjx180.247

Pulusu SSR; Srinivasan A; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Keung C; Wu C; Prosser R; Sawyer E; Rizvi Q-U-A; Su H; Leung W-K; Edmundson A; Cooke S; Mahy G; Thin L; Radford-Smith G; Sparrow M; Andrews JM; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Ng S; Travis S; Lawrance I, 2018, 'P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)', Journal of Crohn's and Colitis, 12, pp. S395 - S396, http://dx.doi.org/10.1093/ecco-jcc/jjx180.698

Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368

Wu Y; Ghaly S; Kerr S; Krishnaprasad K; Prosser R; Jackson B; Hanigan K; Martins D; Mountifield R; Whiteman D; Bampton P; Gearry R; Radford-Smith G; Lawrance IC, 2017, 'P691 UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBD', Journal of Crohn's and Colitis, 11, pp. S433 - S434, http://dx.doi.org/10.1093/ecco-jcc/jjx002.815

Wu Y; Ghaly S; Kerr S; Krishnaprasad K; Martins D; Jackson B; Prosser R; Hanigan K; Mountifield RE; Whiteman D; Bampton PA; Gearry R; Radford-Smith GL; Lawrance I, 2017, 'UV Exposure and Skin Type are More Important than Thiopurine Exposure for Non-Melanoma Skin Cancer Risk in IBD', Gastroenterology, 152, pp. S576 - S576, http://dx.doi.org/10.1016/s0016-5085(17)32082-6

McGonigle TA; Keane KN; Ghaly S; Carter KW; Anderson D; Scott NM; Goodridge HS; Dwyer A; Greenland E; Pixley FJ; Newsholme P; Hart PH, 2017, 'UV Irradiation of Skin Enhances Glycolytic Flux and Reduces Migration Capabilities in Bone Marrow-Differentiated Dendritic Cells.', Am J Pathol, 187, pp. 2046 - 2059, http://dx.doi.org/10.1016/j.ajpath.2017.06.003

Andrews JM; Costello SP; Agarwal AK; Bampton P; Beswick L; Connor S; Ghaly S; O'Connor S; Pudipeddi A; Sechi A; Sparrow M; Walsh AJ, 2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, 46, pp. 377 - 379, http://dx.doi.org/10.1111/imj.12989

Ghaly S; Murray K; Baird A; Martin K; Prosser R; Mill J; Simms LA; Hart PH; Radford-Smith G; Bampton PA; Lawrance IC, 2016, 'High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease.', Inflamm Bowel Dis, 22, pp. 2456 - 2464, http://dx.doi.org/10.1097/MIB.0000000000000894

Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM, 2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, 45, pp. 659 - 666, http://dx.doi.org/10.1111/imj.12732

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Antoniades S; Headon B; Connor S; Lawrance IC; Sparrow M; Walsh AJ; Andrews JM, 2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, 45, pp. 170 - 177, http://dx.doi.org/10.1111/imj.12621

Back to profile page